Recently Viewed
Clear All$10.04
$0.00 (0.00%)As on 04-Nov-2022 09:30EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$433 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$20 Mln
ROE
0 %
ROCE
-- %
P/E Ratio
21.8
P/B Ratio
1.3
Industry P/E
--
EV/EBITDA
-387.2
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$2.2
Face value
--
Shares outstanding
34,500,000
CFO
$--
EBITDA
$--
Net Profit
$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Lux Health Techcquisition Corp. Class A (LUXA)
| 2.4 | 0.3 | 1.1 | 1.7 | -- | -- | -- |
|
BSE Sensex*
| -13.5 | -9.9 | -14.0 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2021
|
|---|---|
|
Lux Health Techcquisition Corp. Class A (LUXA)
| -8.8 |
|
S&P Small-Cap 600
| 25.3 |
|
BSE Sensex
| 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Lux Health Techcquisition Corp. Class A (LUXA)
|
10.0 | 433.4 | 0.0 | 19.8 | -- | -- | 21.8 | 1.3 |
| 10.4 | 143.3 | 0.0 | 0.5 | -- | -- | -- | 1.5 | |
| 9.1 | 262.5 | 0.0 | 11.9 | -- | 5.5 | 29.5 | 1.2 | |
| 9.3 | 410.6 | 0.0 | 3,322,920.1 | -- | -- | 132.1 | 1.0 | |
| 10.1 | 554.0 | 0.0 | 56.0 | -- | -- | 13.2 | 1.1 | |
| 10.1 | 260.2 | 0.0 | 8.6 | -- | -- | 30.5 | 1.3 | |
| 10.0 | 273.8 | 0.0 | 8.6 | -- | -- | 29.5 | 1.3 |
Lux Health Tech Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.... It intends to acquire companies in the healthcare and technology industries. The company was incorporated in 2020 and is based in New York, New York. Read more
CEO & Director
Mr. Joshua Defonzo
CEO & Director
Mr. Joshua Defonzo
Headquarters
New York, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Lux Health Tech Acquisition Corp Class A (LUXA) is $10.04 (NASDAQ) as of 04-Nov-2022 09:30 EDT. Lux Health Tech Acquisition Corp Class A (LUXA) has given a return of 1.72% in the last 1 years.
The P/E ratio of Lux Health Tech Acquisition Corp Class A (LUXA) is 21.85 times as on 11-Nov-2022.
The P/B ratio of Lux Health Tech Acquisition Corp Class A (LUXA) is 1.31 times as on 11-Nov-2022, a 3 discount to its peers’ median range of 1.35 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
3.25
|
-3.21
|
|
2020
|
--
|
--
|
|
2021
|
3.25
|
-3.21
|
|
2020
|
--
|
--
|
The 52-week high and low of Lux Health Tech Acquisition Corp Class A (LUXA) are Rs -- and Rs -- as of 02-Apr-2026.
Lux Health Tech Acquisition Corp Class A (LUXA) has a market capitalisation of $ 433 Mln as on 11-Nov-2022. As per SEBI classification, it is a Small Cap company.
Before investing in Lux Health Tech Acquisition Corp Class A (LUXA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.